US 10653727
Use of gram negative species to treat atopic dermatitis
granted A61KA61K35/74A61K9/0014
Quick answer
US patent 10653727 (Use of gram negative species to treat atopic dermatitis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K35/74, A61K9/0014, A61K9/06, A61P